Dr. Sun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5725 W Las Positas Blvd
Suite 100
Pleasanton, CA 94588Phone+1 925-734-8130Fax+1 925-225-9520
Summary
- Dr. Sun practices both medical oncology and hematology in Pleasanton, CA. He received his medical training at Yale and Stanford. Known for his calm, caring and empathetic demeanor, Dr. Sun considers it the utmost privilege to be able to serve patients who may be confronted with a life-changing diagnosis.
Raised in Vancouver, Canada, Dr. Sun received his B.A. in philosophy from Columbia University, graduating summa cum laude with honors in philosophy. He received his MD and MHS degrees from Yale University where he spent an additional year in the laboratory investigating the tumor microenvironment as a potential target for cancer therapy. He later came to Stanford for internal medicine residency followed by hematology and oncology fellowship, where he was elected a chief fellow and received the Humanism in Medicine award for dedication to patient care.
He has led translational and clinical research to help advance the treatment of aggressive cancers including lung cancers and neuroendocrine tumors. He has published in The New England Journal of Medicine, Nature, Science and The Journal of Thoracic Oncology, among others. He has presented his research at national and international conferences including the World Conference on Lung Cancer, American Society of Clinical Oncology, and the European and the North American Neuroendocrine Tumor Societies. He has co-authored a book chapter on the management of stage IV lung cancers.
In his spare time, he reads novels especially fantasy and science fiction.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2020 - 2023
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2017 - 2020
- Yale School of MedicineClass of 2016
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.Thomas Yang Sun, Brandon Nguyen, Simon B Chen, Yasodha Natkunam, Sukhmani Padda
JTO Clinical and Research Reports. 2023-04-01 - 7 citationsDiffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): clinical characteristics and progression to carcinoid tumor.Thomas Yang Sun, Grace Hwang, Danielle S. Pancirer, Kathleen Hornbacker, Alberto Codima
The European Respiratory Journal. 2021-11-18 - 59 citationsU.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw, Ryohei Katayama, Yuki Shimizu
Clinical Cancer Research. 2020-09-15
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
External Links
- Current jobhttps://stanfordhealthcare.org/doctors/s/thomas-yang-sun.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: